Get started
Johnson & JohnsonJohnson & JohnsonJohnson & Johnson

Johnson & Johnson

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

JNJCL chart


Full chart

Key facts today


Johnson & Johnson has a licensing agreement with Nanobiotix SA to develop NBTXR3, an experimental radiotherapy for treating specific skin melanoma patients.
Analyze the impactAnalyze the impact

JNJCL upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪407.60 T‬ CLP
Dividend yield (indicated)
2.93%
Price to earnings Ratio (TTM)
20
Basic EPS (TTM)
8,810 CLP
Net income (FY)
‪14.04 T‬ CLP
Revenue (FY)
‪88.64 T‬ CLP
Shares float
‪2.41 B‬
Beta (1Y)
0.20

Employees


Employees (FY)
‪139.8 K‬
Change (1Y)
‪+7.9 K‬ +5.99%
Revenue / Employee (1Y)
‪634.06 M‬ CLP
Net income / Employee (1Y)
‪100.41 M‬ CLP

About Johnson & Johnson


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Joaquin Duato
Website
jnj.com
Headquarters
New Brunswick
Founded
1887
ISIN
US4781601046
FIGI
BBG00YFST5R5
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Check out other big names from the same industry as JNJCL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

JNJCL news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

JNJCL highest yielding bonds


US478160CM4
Johnson & Johnson 3.5% 15-JAN-2048
Yield to maturity
5.16%
Maturity date
Jan 15, 2048
JNJJ
Johnson & Johnson 3.75% 03-MAR-2047
Yield to maturity
5.14%
Maturity date
Mar 3, 2047
US478160CX0
Johnson & Johnson 5.25% 01-JUN-2054
Yield to maturity
5.13%
Maturity date
Jun 1, 2054
US478160BV5
Johnson & Johnson 3.7% 01-MAR-2046
Yield to maturity
5.13%
Maturity date
Mar 1, 2046
US478160CS1
Johnson & Johnson 2.25% 01-SEP-2050
Yield to maturity
5.10%
Maturity date
Sep 1, 2050
US478160CT9
Johnson & Johnson 2.45% 01-SEP-2060
Yield to maturity
5.08%
Maturity date
Sep 1, 2060
US478160BA1
Johnson & Johnson 4.85% 15-MAY-2041
Yield to maturity
4.91%
Maturity date
May 15, 2041
US478160CR3
Johnson & Johnson 2.1% 01-SEP-2040
Yield to maturity
4.89%
Maturity date
Sep 1, 2040
JNJ4077469
Johnson & Johnson 4.5% 05-DEC-2043
Yield to maturity
4.88%
Maturity date
Dec 5, 2043
US478160CL6
Johnson & Johnson 3.4% 15-JAN-2038
Yield to maturity
4.69%
Maturity date
Jan 15, 2038
JNJ.GR
Johnson & Johnson 5.85% 15-JUL-2038
Yield to maturity
4.66%
Maturity date
Jul 15, 2038

See all JNJCL bonds 

Sparks


Curated watchlists where JNJCL is featured.

See all sparks 

Frequently Asked Questions


The current price of JNJCL is 172,900 CLP — it has decreased by −0.17% in the past 24 hours. Watch Johnson & Johnson stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BCS exchange Johnson & Johnson stocks are traded under the ticker JNJCL.
We've gathered analysts' opinions on Johnson & Johnson future price: according to them, JNJCL price has a max estimate of 191,021.97 CLP and a min estimate of 148,042.02 CLP. Watch JNJCL chart and read a more detailed Johnson & Johnson stock forecast: see what analysts think of Johnson & Johnson and suggest that you do with its stocks.
JNJCL reached its all-time high on Jul 12, 2022 with the price of 177,790 CLP, and its all-time low was 115,030 CLP and was reached on Mar 11, 2021. View more price dynamics on JNJCL chart.
See other stocks reaching their highest and lowest prices.
JNJCL stock is 0.46% volatile and has beta coefficient of 0.20. Track Johnson & Johnson stock price on the chart and check out the list of the most volatile stocks — is Johnson & Johnson there?
Today Johnson & Johnson has the market capitalization of ‪402.92 T‬, it has increased by 0.68% over the last week.
Yes, you can track Johnson & Johnson financials in yearly and quarterly reports right on TradingView.
Johnson & Johnson is going to release the next earnings report on Oct 14, 2025. Keep track of upcoming events with our Earnings Calendar.
JNJCL earnings for the last quarter are ‪2.59 K‬ CLP per share, whereas the estimation was ‪2.51 K‬ CLP resulting in a 3.29% surprise. The estimated earnings for the next quarter are ‪2.64 K‬ CLP per share. See more details about Johnson & Johnson earnings.
Johnson & Johnson revenue for the last quarter amounts to ‪22.21 T‬ CLP, despite the estimated figure of ‪21.38 T‬ CLP. In the next quarter, revenue is expected to reach ‪22.79 T‬ CLP.
JNJCL net income for the last quarter is ‪5.18 T‬ CLP, while the quarter before that showed ‪10.49 T‬ CLP of net income which accounts for −50.60% change. Track more Johnson & Johnson financial stats to get the full picture.
Yes, JNJCL dividends are paid quarterly. The last dividend per share was ‪1.26 K‬ CLP. As of today, Dividend Yield (TTM)% is 2.92%. Tracking Johnson & Johnson dividends might help you take more informed decisions.
Johnson & Johnson dividend yield was 3.40% in 2024, and payout ratio reached 84.80%. The year before the numbers were 3.00% and 84.93% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 19, 2025, the company has ‪139.8 K‬ employees. See our rating of the largest employees — is Johnson & Johnson on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Johnson & Johnson EBITDA is ‪27.34 T‬ CLP, and current EBITDA margin is 31.71%. See more stats in Johnson & Johnson financial statements.
Like other stocks, JNJCL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Johnson & Johnson stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Johnson & Johnson technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Johnson & Johnson stock shows the buy signal. See more of Johnson & Johnson technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.